Endocrine Disruptor Assessment Under CLP: Key Challenges and How We Delivered a Robust, Regulator-Ready Outcome
Under CLP Delegated Regulation (EU) 2023/707, companies must assess whether substances meet criteria for endocrine disruption in humans (ED HH) or the environment (ED ENV). This post outlines how RegSurance conducted a full ED assessment for a high-volume industrial chemical using a transparent weight-of-evidence approach aligned with EFSA–ECHA Guidance 2018, resulting in a defensible, non-classification […]
Understanding Dutch EPR: How RegSurance Helped a Multinational Client Save Costs
What Are My EPR Obligations in the Netherlands? If your company sells packaged products in the Dutch market, you probably need to follow EPR rules (Extended Producer Responsibility). That means reporting the packaging you place on the Dutch market—and taking responsibility for what happens to it after use. Sounds simple, but the details can get […]